| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1437ae9db1ed46e46bb0fea6f52e76b6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate |
2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d05756544421aa39a559cbe4a47c7707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f685432abab1ed8aafaf6d808aba120 |
| publicationDate |
2006-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006257861-A1 |
| titleOfInvention |
Screening assay for inhibitors of severe acute respiratory syndrome (SARS) using SELDI-TOF Mass Spectrometry |
| abstract |
Mass spectrometric methods directed to screening libraries of compounds for agents that inhibit entry of Severe Acute Respiratory Syndrome (SARS) coronavirus (CoV) into cells are provided, along with methods for comparatively evaluating inhibitors of the SARS CoV. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8754203-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005222067-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112748173-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111474350-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112098643-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8362417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8106351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010219338-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111830120-A |
| priorityDate |
2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |